Ann M Chodara1, Aimée Wattiaux2, Christie M Bartels3. 1. Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, WI, USA. 2. Rheumatology Division, Department of Medicine, University of Wisconsin (UW) School of Medicine and Public Health (SMPH), 1685 Highland Ave, Rm 4132, 53705-2281, Madison, WI, USA. 3. Rheumatology Division, Department of Medicine, University of Wisconsin (UW) School of Medicine and Public Health (SMPH), 1685 Highland Ave, Rm 4132, 53705-2281, Madison, WI, USA. cb4@medicine.wisc.edu.
Abstract
ᅟ: The increase in cardiovascular disease (CVD) risk in rheumatoid arthritis (RA) is well known; however, appropriate management of this elevated risk in rheumatology clinics is less clear. PURPOSE OF REVIEW: By critically reviewing literature published within the past 5 years, we aim to clarify current knowledge and gaps regarding CVD risk management in RA. RECENT FINDINGS: We examine recent guidelines, recommendations, and evidence and discuss three approaches: (1) RA-specific management including treat-to-target and medication management, (2) assessment of comprehensive individual risk, and (3) targeting traditional CVD risk factors (hypertension, smoking, hyperlipidemia, diabetes, obesity, and physical inactivity) at a population level. Considering that 75% of US RA visits occur in specialty clinics, further research is needed regarding evidence-based strategies to manage and reduce CVD risk in RA. This review highlights clinical updates including US cardiology and international professional society guidelines, successful evidence-based population approaches from primary care, and novel opportunities in rheumatology care to reduce CVD risk in RA.
ᅟ: The increase in cardiovascular disease (CVD) risk in rheumatoid arthritis (RA) is well known; however, appropriate management of this elevated risk in rheumatology clinics is less clear. PURPOSE OF REVIEW: By critically reviewing literature published within the past 5 years, we aim to clarify current knowledge and gaps regarding CVD risk management in RA. RECENT FINDINGS: We examine recent guidelines, recommendations, and evidence and discuss three approaches: (1) RA-specific management including treat-to-target and medication management, (2) assessment of comprehensive individual risk, and (3) targeting traditional CVD risk factors (hypertension, smoking, hyperlipidemia, diabetes, obesity, and physical inactivity) at a population level. Considering that 75% of US RA visits occur in specialty clinics, further research is needed regarding evidence-based strategies to manage and reduce CVD risk in RA. This review highlights clinical updates including US cardiology and international professional society guidelines, successful evidence-based population approaches from primary care, and novel opportunities in rheumatology care to reduce CVD risk in RA.
Authors: M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed Journal: Ann Rheum Dis Date: 2009-09-22 Impact factor: 19.103
Authors: Saedis Saevarsdottir; Sara Wedrén; Maria Seddighzadeh; Camilla Bengtsson; Annmarie Wesley; Staffan Lindblad; Johan Askling; Lars Alfredsson; Lars Klareskog Journal: Arthritis Rheum Date: 2011-01
Authors: Cynthia S Crowson; Eric L Matteson; Veronique L Roger; Terry M Therneau; Sherine E Gabriel Journal: Am J Cardiol Date: 2012-04-20 Impact factor: 2.778
Authors: Shubhasree Banerjee; Michael D George; Sukhraj Singh; Jennifer Tchervenkov; Amber Van Heusen; Mohamed Tageldin; Mark Riley; Muhammad Saad Shaukat; Nicholas Demenagas; Kevin Le; Tiffany Oliveira; Sooyeon Kwon; Paul Feustel; Joel M Kremer Journal: ACR Open Rheumatol Date: 2020-04-20
Authors: David Hupin; Philip Sarajlic; Ashwin Venkateshvaran; Cecilia Fridén; Birgitta Nordgren; Christina H Opava; Ingrid E Lundberg; Magnus Bäck Journal: Front Med (Lausanne) Date: 2021-12-15
Authors: Jorge D Guerra; Andres Belmont De Santiago; Shirley Reed; Kendall P Hammonds; Courtney Shaver; Robert J Widmer; Beth A Scholz Journal: Clin Rheumatol Date: 2022-08-16 Impact factor: 3.650
Authors: Anna Łuczak; Rafał Małecki; Michał Kulus; Marta Madej; Ewa Szahidewicz-Krupska; Adrian Doroszko Journal: Nutrients Date: 2021-06-17 Impact factor: 5.717